Vaxart Inc (VXRT)
0.7166
-0.03
(-3.82%)
USD |
NASDAQ |
Apr 24, 13:42
Vaxart Free Cash Flow: -72.32M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -72.32M |
| September 30, 2023 | -86.92M |
| June 30, 2023 | -93.32M |
| March 31, 2023 | -103.62M |
| December 31, 2022 | -104.38M |
| September 30, 2022 | -93.19M |
| June 30, 2022 | -87.10M |
| March 31, 2022 | -74.24M |
| December 31, 2021 | -64.99M |
| September 30, 2021 | -59.83M |
| June 30, 2021 | -53.80M |
| March 31, 2021 | -38.97M |
| December 31, 2020 | -24.97M |
| September 30, 2020 | -17.11M |
| June 30, 2020 | -12.00M |
| March 31, 2020 | -11.95M |
| December 31, 2019 | -13.94M |
| September 30, 2019 | -16.03M |
| June 30, 2019 | -17.11M |
| March 31, 2019 | -9.73M |
| December 31, 2018 | -15.26M |
| September 30, 2018 | -14.06M |
| June 30, 2018 | -13.03M |
| March 31, 2018 | -18.73M |
| December 31, 2017 | -19.50M |
| Date | Value |
|---|---|
| September 30, 2017 | -23.80M |
| June 30, 2017 | -30.00M |
| March 31, 2017 | -30.20M |
| December 31, 2016 | -25.80M |
| September 30, 2016 | -25.90M |
| June 30, 2016 | -14.30M |
| March 31, 2016 | -15.10M |
| December 31, 2015 | -7.30M |
| September 30, 2015 | 2.80M |
| June 30, 2015 | -9.70M |
| March 31, 2015 | 0.80M |
| December 31, 2014 | 0.70M |
| September 30, 2014 | -8.70M |
| June 30, 2014 | -3.40M |
| March 31, 2014 | -15.95M |
| December 31, 2013 | -18.77M |
| September 30, 2013 | -11.89M |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | -6.293M |
| June 30, 2012 | -9.875M |
| March 31, 2012 | -8.079M |
| December 31, 2011 | -15.17M |
| September 30, 2011 | -16.16M |
Free Cash Flow Range, Past 5 Years
-104.38M
Minimum
Dec 2022
-11.95M
Maximum
Mar 2020
-55.04M
Average
-59.83M
Median
Sep 2021
Free Cash Flow Benchmarks
| Novavax Inc | -772.77M |
| aTyr Pharma Inc | -37.44M |
| Allogene Therapeutics Inc | -239.25M |
| AIM ImmunoTech Inc | -21.85M |
| Protalix BioTherapeutics Inc | -2.467M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -13.52M |
| Cash from Investing (Quarterly) | 15.10M |
| Cash from Financing (Quarterly) | -0.066M |
| Free Cash Flow Per Share (Quarterly) | -0.0946 |
| Free Cash Flow to Equity (Quarterly) | -13.42M |
| Free Cash Flow to Firm (Quarterly) | -13.12M |
| Free Cash Flow Yield | -70.99% |